9-Minute Trade Unlocked $67,548 Income Avalanche -- Copy and Paste

Forget cryptos, pot stocks, and other "shiny object" investments. Instead, you could collect an average of $185 every day of the year with this "boring" trade strategy Forbes magazine says is "like finding money in the street."

Popular

Bristol Myers Acquired MyoKardia Drops Fulcrum Agreement, Ending Cardiomyopathy Research Deal

MyoKardia, a Bristol Myers unit, is terminating its agreement with Fulcrum Therapeutics, ending a cardiomyopathy research deal set to expire in June 2025.

CDC Considers New Autism Study As Vaccine Safety Debate Persists

The CDC is planning a large study on potential vaccinAutism's links, despite extensive research dismissing any connection.

13-Second Trump Video Could Trigger AI Shock - Ad

Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... Just released a video with this 13-second Trump clip about the current AI boom. Please, do NOT buy any AI stock before watching that clip. What President Trump said in that clip could have implications for this AI boom.

Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder

Pliant Therapeutics discontinued its BEACON-IPF trial for bexotegrast due to safety concerns but observed early efficacy. The company plans further data analysis.

Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?

Exelixis reaffirmed its 2025 sales guidance of $2.15-$2.25 billion and reported sustained long-term efficacy for Cabometyx in advanced renal cell carcinoma.

My No. 1 "Nuclear Renaissance" Stock Pick for 2025 - Ad

Bill Gates, Warren Buffett, Elon Musk, and Jeff Bezos Are "Silent Partners" on the Next Phase of A.I. One Little-Known 'Savior Stock' - trading at just $8 right now - Offers a Rare Opportunity to Profit in the NEXT A.I.

Kiniksa Pharmaceuticals Stock Is Attractive From Valuation Perspective-JP Morgan Analyst

Kiniksa shifts focus to cardiovascular indications, halts abiprubart in Sjögren's, ends its AstraZeneca deal, and advances KPL-387 for recurrent pericarditis.

Nvidia Is About to Shock the World: March 17th - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: March 17th! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Pliant Therapeutics Drops IPF Drug Trial After Review, Analyst Flags Uncertain Future

Pliant Therapeutics ends its Phase 2b IPF trial for bexotegrast, prompting a Needham downgrade to Hold due to limited catalysts and pipeline challenges.

What happens to your HSA in retirement?

Health savings accounts can be valuable components of individuals’ savings toolkits, especially for those who can afford to pay their actual healthcare expenses out of pocket while leaving their health savings account assets in place to grow.

Big Tech Is Barreling Toward a $17 Trillion Reckoning - Ad

While everyday investors keep piling into names like Nvidia, Apple, and Amazon... the owners of those very companies are dumping their OWN shares at a record pace. Now, "America's top trader" is warning that big tech could be barreling right toward another dot-com style implosion. 

Maryland's largest provider for Medicaid enrollees gets its accreditation suspended

ANNAPOLIS, Md. (AP) — Maryland's largest managed care organization for Medicaid enrollees has had its accreditation suspended due to concerns with credentialing and quality reviews for its providers, a state health department official said Friday.

The Same "Magic Pattern" That Predicted Trump's Win Now Predicts These Niche-Trades Will Surge! - Ad

It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge as President Trump fuels America's economic boom. For only $19, you can see how millionaire-trader Jeff Clark has used this "Magic Pattern" for over 40 years to generate over 1,000 winning trade recommendations.

The number of babies born in South Korea last year rebounded for the first time in nearly a decade

SEOUL, South Korea (AP) — The number of babies born in South Korea rebounded for the first time in nine years in 2024, welcome news for a country grappling with one of the the world’s most serious .

Republican lawmakers look for ways to weaken state judges

TOPEKA, Kansas (AP) — Measures in several state legislatures this year have called for new approaches to weaken the power of judges.

22X Better Than Bitcoin... Without Crypto - Ad

For every $1,000 made in Bitcoin... you could have made as much as $22,000 with this strategy. legendary former hedge fund manager Larry Benedict calls it "Bitcoin Skimming." And get this... it's CRUSHING Bitcoin's returns. If you want to get in on the ground floor then watch this free interview NOW.

Court Dismisses Novartis Challenge To Medicare Drug Price Negotiation Program

A federal court rejected Novartis' legal challenge to the Medicare Drug Price Negotiation Program, ruling that it does not impose unconstitutional fines, takings, or compelled speech.

In Brazil, mining giant Vale is sued over metal contamination found in Indigenous peoples

BRASILIA, Brazil (AP) — Brazil’s Federal Prosecutor’s Office is suing the giant mining company Vale, the Brazilian government and the Amazon state of Para over heavy metal contamination in the bodies of Xikrin Indigenous people.

Are you owed an extra $2,105 a month in extra cash? - Ad

A little-known "loophole" has allowed a handful of regular Americans to legally collect over $109,200,000 in bonus cash. And today's your chance to join them. It doesn't matter how old you are or even how much money you make. And my research shows there's no way you can be denied from taking part in this opportunity.

Elizabeth Holmes fails to overturn her Theranos fraud conviction

SAN FRANCISCO (AP) — , the disgraced founder of Theranos, will remain in prison after losing a bid Monday to overturn her , with a federal appeals court saying she hadn’t proved there were legal missteps during her trial for defrauding investors with false claims of what her blood-testing startup could achieve.

Is This Elon's True Agenda? - Ad

After you see the new research my Boston think tank just put together...You'll view Elon Musk in a totally new light. It will all suddenly make sense. In fact, it's been building up to what could play out over the next 100 days.

Motive in Pennsylvania hospital shooting unclear, but officials say man had recent contact with ICU

YORK, Pa. (AP) — The man who authorities say entered a Pennsylvania hospital with zip ties and a pistol over the weekend had recent contact with the hospital's intensive care unit, where he took staff members hostage and was killed in a shootout that left a police officer dead and others injured.

Buffett, Bezos, and Congress Are Betting Big on This One Sector - Ad

This corner of the market is NOT artificial intelligence... Crypto... or any other familiar sector or strategy. Instead...It's a sector that the U.S. Gov't spends 6-TIMES more on, than our own ENTIRE military defense budget. Don't let recent market uncertainty keep you in the dark on this massive opportunity.

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments , federal regulators said Friday.

Why Is Penny Stock Aptose Biosciences Trading Higher On Thursday?

Aptose Biosciences advances its Phase 1/2 TUSCANY trial, escalating tuspetinib dosing after a favorable safety review. Enrollment continues across U.S. sites.

JFK, 9/11... And Now This? - Ad

Jim Rickards says we'll never forget April 11, 2025. Jim outlines a crash so terrible it may even have the power to wipe out the checking and savings accounts at your bank... Along with 40% of the market. Jim is one of America's best geopolitical analysts... All you need to know is in a quick summary of his latest book.

Is spending all day on your feet at work an occupational hazard?

NEW YORK (AP) — While traveling in Europe, Margaux Lantelme noticed something different about the : they did their work sitting down. It was a stark contrast to Chicago, where Lantelme and cashiers typically spend eight hours a day on their feet.

EU publishes farming sector reform 'vision' which aims to cut red tape and redistribute subsidies

BRUSSELS (AP) — The European Union's executive on Wednesday heeded the call of activist agricultural organizations and the complaints of hard-right parties by proposing a vision for the future of farming and food production that aims to cut deep into the complicated rules designed to protect the environment.

Warning: China Launches AI Attack on America - Ad

China just launched what can only be described as an AI attack on America. And according to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... President Trump is already planning a counter attack. And it's creating an incredible opportunity for you in this small group of AI stocks.

Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges

Moderna misses Q4 EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake challenges.

A $19 Secret to Potentially Life-Changing Gains - Ad

It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge as President Trump fuels America's economic boom. For only $19, you can see how millionaire-trader Jeff Clark has used this "Magic Pattern" for over 40 years to generate over 1,000 winning trade recommendations.

Musk's DOGE Under Treasury Scrutiny, Trump's Tariffs Impacting Soda Industry, And More

The past week has been a whirlwind of news, with the spotlight on Elon Musk's DOGE and its access to federal payment systems.

Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service